Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manhattan Associates Inc (MANH) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

Manhattan Associates IncTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

Manhattan Associates Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? Manhattan Associates Inc trades at $206.18 (market cap $12.06B), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2× Manhattan Associates Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Manhattan Associates Inc for 12 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

MANHROIV
Market Cap
$12.06B$24.72B
Volume
376,1506,279,442
Sector
TechnologyHealth
52-Week High
$223.76$41.81
52-Week Low
$120.88$16.04
Typical Hold Time
12 Days0 Days
Enterprise Value
$11.93B$20.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manhattan Associates Inc

MANH trades at $202.11, down 0.36% on the day, with a bearish technical signal and key support at $201. The company shows strong profitability with a net income margin of 18.67% and has beaten earnings estimates for the last three quarters. Recent news includes a law firm investigation into fiduciary duties and a product launch of Editions for its supply chain solutions.

The outlook is mixed: strong fundamentals and analyst buy ratings support upside to the $210.50 consensus target, but technical weakness and the ongoing legal investigation pose near-term risks. Earnings growth remains the key catalyst for further price appreciation.

Roivant Sciences Ltd. Common Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MANH

No sentiment data available yet.

ROIV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →